Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19

Chia Siang Kow; Syed S. Hasan

doi:10.1097/MJT.0000000000001441

Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e616-e619
Number of pages	4
Journal	American Journal of Therapeutics
Volume	28
Issue number	5
Early online date	6 Aug 2021
DOIs	https://doi.org/10.1097/MJT.0000000000001441
Publication status	Published - 6 Sep 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/MJT.0000000000001441Licence: Unspecified

Cite this

@article{bb21dfd3828041ee911c3f2c8e36d5c3,

title = "Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19",

keywords = "COVID-19, Ivermectin, Randomised controlled trial",

author = "Kow, {Chia Siang} and Hasan, {Syed S.}",

year = "2021",

month = sep,

day = "6",

doi = "10.1097/MJT.0000000000001441",

language = "English",

volume = "28",

pages = "e616--e619",

journal = "American Journal of Therapeutics",

issn = "1075-2765",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19

AU - Kow, Chia Siang

AU - Hasan, Syed S.

PY - 2021/9/6

Y1 - 2021/9/6

KW - COVID-19

KW - Ivermectin

KW - Randomised controlled trial

UR - http://www.scopus.com/inward/record.url?scp=85116172049&partnerID=8YFLogxK

U2 - 10.1097/MJT.0000000000001441

DO - 10.1097/MJT.0000000000001441

M3 - Letter

C2 - 34387564

VL - 28

SP - e616-e619

JO - American Journal of Therapeutics

JF - American Journal of Therapeutics

SN - 1075-2765

IS - 5

ER -

Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19

UN SDGs

Access to Document

Other files and links

Cite this